Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China · Delayed Price · Currency is CNY 19.96
+0.13 (0.66%)
Jun 1, 2026, 3:00 PM CST
Aurisco Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,052 | 10,175 | 8,579 | 10,488 | 10,029 | 8,830 | |
Market Cap Growth | -5.42% | 18.61% | -18.20% | 4.58% | 13.58% | 38.75% |
Enterprise Value | 8,104 | 10,126 | 8,317 | 10,056 | 9,726 | 8,296 |
Last Close Price | 19.96 | 25.05 | 20.82 | 25.21 | 23.96 | 21.25 |
PE Ratio | 20.72 | 22.65 | 24.18 | 36.24 | 47.54 | 52.34 |
Forward PE | 14.68 | 16.73 | 18.69 | 30.47 | 39.82 | - |
PS Ratio | 4.78 | 5.99 | 5.81 | 8.31 | 9.95 | 10.99 |
PB Ratio | 2.96 | 3.83 | 3.68 | 5.33 | 5.96 | 5.86 |
P/TBV Ratio | 3.15 | 4.08 | 3.95 | 5.68 | 6.46 | 6.02 |
P/FCF Ratio | 60.87 | 142.46 | - | 130.89 | - | - |
P/OCF Ratio | 16.64 | 24.14 | 25.81 | 27.20 | 60.27 | 43.81 |
EV/Sales Ratio | 4.81 | 5.97 | 5.64 | 7.97 | 9.65 | 10.33 |
EV/EBITDA Ratio | 13.13 | 15.53 | 17.73 | 28.49 | 35.61 | 35.42 |
EV/EBIT Ratio | 16.81 | 19.01 | 21.53 | 36.07 | 46.71 | 45.40 |
EV/FCF Ratio | 61.26 | 141.77 | - | 125.50 | - | - |
Debt / Equity Ratio | 0.36 | 0.36 | 0.41 | 0.06 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 1.57 | 1.46 | 2.00 | 0.33 | 0.19 | 0.08 |
Debt / FCF Ratio | 7.33 | 13.43 | - | 1.46 | - | - |
Net Debt / Equity Ratio | 0.02 | 0.00 | -0.05 | -0.22 | -0.20 | -0.28 |
Net Debt / EBITDA Ratio | 0.09 | 0.01 | -0.26 | -1.22 | -1.24 | -1.82 |
Net Debt / FCF Ratio | 0.40 | 0.07 | 0.58 | -5.35 | 6.81 | 8.70 |
Asset Turnover | 0.41 | 0.42 | 0.46 | 0.55 | 0.54 | 0.49 |
Inventory Turnover | 1.13 | 1.13 | 1.15 | 1.18 | 1.28 | 1.45 |
Quick Ratio | 2.80 | 2.67 | 2.68 | 1.69 | 1.92 | 3.06 |
Current Ratio | 4.22 | 3.95 | 3.85 | 2.73 | 3.38 | 4.87 |
Return on Equity (ROE) | 15.26% | 18.01% | 16.50% | 15.83% | 13.05% | 11.63% |
Return on Assets (ROA) | 7.40% | 8.22% | 7.49% | 7.56% | 6.93% | 7.02% |
Return on Invested Capital (ROIC) | 15.40% | 18.95% | 17.95% | 16.99% | 14.85% | 16.68% |
Return on Capital Employed (ROCE) | 12.80% | 14.40% | 11.60% | 13.40% | 12.20% | 12.00% |
Earnings Yield | 4.89% | 4.42% | 4.14% | 2.76% | 2.10% | 1.91% |
FCF Yield | 1.64% | 0.70% | -2.42% | 0.76% | -0.50% | -0.56% |
Dividend Yield | 1.71% | 1.36% | 1.39% | 0.87% | 0.67% | 0.61% |
Payout Ratio | 31.50% | 27.63% | 26.72% | 23.15% | 24.81% | 28.52% |
Buyback Yield / Dilution | -3.37% | -2.44% | 2.21% | -0.48% | -1.00% | -7.31% |
Total Shareholder Return | -1.65% | -1.08% | 3.60% | 0.40% | -0.33% | -6.69% |